- Home
- MRNA vs WTW Comparison
MRNA vs WTW Comparison
Compare MRNA & WTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- WTW
- Stock Information
- Founded
- MRNA 2010
- WTW 1828
- Country
- MRNA United States
- WTW United Kingdom
- Employees
- MRNA N/A
- WTW N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- WTW Specialty Insurers
- Sector
- MRNA Health Care
- WTW Finance
- Exchange
- MRNA Nasdaq
- WTW Nasdaq
- Market Cap
- MRNA 34.6B
- WTW 29.8B
- IPO Year
- MRNA 2018
- WTW N/A
- Fundamental
- Price
- MRNA $54.82
- WTW $291.14
- Analyst Decision
- MRNA Hold
- WTW Buy
- Analyst Count
- MRNA 16
- WTW 15
- Target Price
- MRNA $95.93
- WTW $311.13
- AVG Volume (30 Days)
- MRNA 5.0M
- WTW 563.7K
- Earning Date
- MRNA 11-07-2024
- WTW 10-31-2024
- Dividend Yield
- MRNA N/A
- WTW 1.21%
- EPS Growth
- MRNA N/A
- WTW 5.21
- EPS
- MRNA N/A
- WTW 10.44
- Revenue
- MRNA $5,050,000,000.00
- WTW $9,686,000,000.00
- Revenue This Year
- MRNA N/A
- WTW $5.98
- Revenue Next Year
- MRNA $5.29
- WTW $5.17
- P/E Ratio
- MRNA N/A
- WTW $27.88
- Revenue Growth
- MRNA N/A
- WTW 6.70
- 52 Week Low
- MRNA $54.82
- WTW $203.36
- 52 Week High
- MRNA $170.47
- WTW $303.42
- Technical
- Relative Strength Index (RSI)
- MRNA 25.28
- WTW 50.25
- Support Level
- MRNA $55.70
- WTW $288.84
- Resistance Level
- MRNA $59.73
- WTW $296.64
- Average True Range (ATR)
- MRNA 2.17
- WTW 5.53
- MACD
- MRNA 0.29
- WTW -0.53
- Stochastic Oscillator
- MRNA 0.00
- WTW 28.06
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About WTW Willis Towers Watson Public Limited Company
In January 2016, Towers Watson and Willis Group merged to form Willis Towers Watson, a global advisory, insurance brokerage, and solutions company. The company operates in two business segments: health, wealth, and career (its consulting operations) and risk and brokering (its brokerage operations). It has about 48,000 employees.